Hunt G E, Atrens D M, Johnson G F
Eur J Pharmacol. 1981 Mar 5;70(1):59-63. doi: 10.1016/0014-2999(81)90432-5.
It has been suggested that the tetracyclic antidepressant mianserin may be an antagonist at inhibitory presynaptic alpha-adrenoceptors. If mianserin exerted a selective antagonist effect it should produce effects that are essentially opposite to those of a selective agonist such as clonidine. This hypothesis was investigated in a shuttle-box self-stimulation model previously shown to be sensitive to alpha-adrenergic drugs. In this model a presynaptic alpha-adrenoceptor antagonist would be expected to enhance self-stimulation and to reverse the inhibitory effects of clonidine. Mianserin (2.5-4.0 mg/kg) did not enhance self-stimulation, but instead produced a selective inhibition of reward. Further, mianserin did not reverse the inhibitory effects of clonidine on self-stimulation. These data suggest that if mianserin is an antagonist of the presynaptic alpha-adrenoceptors it is not a selective antagonist. It is possible that the presynaptic alpha-adrenoceptor antagonism may be effects on postsynaptic alpha-adrenoceptors and/or on a presynaptic noradrenaline reuptake mechanism.
有人提出四环类抗抑郁药米安色林可能是抑制性突触前α-肾上腺素能受体的拮抗剂。如果米安色林发挥选择性拮抗作用,它应该产生与选择性激动剂(如可乐定)基本相反的效果。在先前已证明对α-肾上腺素能药物敏感的穿梭箱自我刺激模型中对这一假设进行了研究。在该模型中,突触前α-肾上腺素能受体拮抗剂预计会增强自我刺激并逆转可乐定的抑制作用。米安色林(2.5 - 4.0毫克/千克)并未增强自我刺激,反而产生了对奖赏的选择性抑制。此外,米安色林并未逆转可乐定对自我刺激的抑制作用。这些数据表明,如果米安色林是突触前α-肾上腺素能受体的拮抗剂,它并非选择性拮抗剂。突触前α-肾上腺素能受体拮抗作用可能是对突触后α-肾上腺素能受体和/或突触前去甲肾上腺素再摄取机制产生的影响。